Name | R-FARMA, OOO |
|---|
INN | 0608010860 |
|---|
KPP | 060801001 |
|---|
OGRN | 1080608003068 |
|---|
OKPO | 84609143 |
|---|
Address | 386102, Respublika Ingushetiya, g Nazran', ter Tsentral'nyy Okrug, ul Moskovskaya, d. D. 31, of. 47 |
|---|
Phone | Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 46.46 | Core activity | Wholesale of pharmaceutical goods |
Registration date | 18.11.2008 |
|---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N1 po Respublike Ingushetiya |
|---|
|
R-FARMA, OOO (Ingushetia, Republic; INN 0608010860) was registered on 18 Nov 2008. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of R-FARMA, OOO - Limited liability companies. Form of ownership of R-FARMA, OOO - Private property. Principal activities of R-FARMA, OOO: wholesale of pharmaceutical goods (46.46). |
Economic indicators2023
Net profit (RAS) of R-FARMA, OOO grew over 2023 1.80 times to 3.09 million RUB from 1.72 million RUB over 2022, the company informed. Revenue increased in the accounting period 5.57 times to 100.21 million RUB from 17.99 million RUB over 2022; cost of goods sold grew 5.97 times to 97.12 million RUB from 16.27 million RUB; sales profit went up 1.80 times to 3.09 million RUB from 1.72 million RUB. 2022
Net profit (RAS) of R-FARMA, OOO dropped in 2022 2.20 times to 1.72 million RUB from 3.78 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period 3.21 times to 17.99 million RUB from 57.74 million RUB in 2021; cost of goods sold decreased 3.32 times to 16.27 million RUB from 53.96 million RUB; sales profit fell 2.20 times to 1.72 million RUB from 3.78 million RUB. 2021
Net profit (RAS) of R-FARMA, OOO dropped in 2021 by 29.60% to 3.78 million RUB from 5.37 million RUB over the same period in 2020, the company informed. Revenue decreased in the accounting period by 42.42% to 57.74 million RUB from 100.27 million RUB in 2020; cost of goods sold decreased by 43.14% to 53.96 million RUB from 94.90 million RUB; sales profit fell by 29.60% to 3.78 million RUB from 5.37 million RUB. 2020
Net profit (RAS) of R-FARMA, OOO grew over 2020 2.03 times to 5.30 million RUB from 2.62 million RUB over 2019, the company informed. Revenue increased in the accounting period 3.03 times to 100.27 million RUB from 33.11 million RUB over 2019; cost of goods sold grew 3.11 times to 94.97 million RUB from 30.50 million RUB; sales profit went up 2.03 times to 5.30 million RUB from 2.62 million RUB. 2019
Net profit (RAS) of R-FARMA, OOO grew over 2019 by 29.20% to 2.62 million RUB from 2.02 million RUB over 2018, the company informed. Revenue increased in the accounting period by 21.34% to 33.11 million RUB from 27.29 million RUB over 2018; cost of goods sold grew by 20.82% to 30.50 million RUB from 25.24 million RUB; sales profit went up by 27.75% to 2.62 million RUB from 2.05 million RUB. 2018
Net profit (RAS) of R-FARMA, OOO made up 2.02 million RUB over 2018 compared to net loss of 238.00 thousand RUB over 2017, the company informed. Revenue decreased in the accounting period 2.01 times to 27.29 million RUB from 54.78 million RUB in 2017; cost of goods sold decreased 2.18 times to 25.24 million RUB from 54.93 million RUB; sales profit made up 2.05 million RUB compared to sales loss of 238.00 thousand RUB. 2017
Net profit (RAS) of R-FARMA, OOO made up 0 RUB over 2017 compared to 1.13 million RUB over 2016, the company informed. Revenue decreased in the accounting period Infinity times to 0.00 thousand RUB from 54.80 million RUB in 2016; cost of goods sold decreased Infinity times to 0.00 thousand RUB from 53.09 million RUB; sales profit made up 0 RUB compared to 1.71 million RUB. 2016
Net profit (RAS) of R-FARMA, OOO dropped in 2016 3.15 times to 427.00 thousand RUB from 1.34 million RUB over the same period in 2015, the company informed. Revenue decreased in the accounting period by 9.39% to 54.80 million RUB from 60.47 million RUB in 2015; cost of goods sold decreased by 9.48% to 53.09 million RUB from 58.65 million RUB; sales profit went up by 1.79% to 1.71 million RUB from 1.68 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|